For any medication to work, people must be willing and able to take it. This is particularly true for antiviral therapy for HIV. The newest generation of HIV therapy focuses on long-acting injectable medication, which provides a treatment regimen that is easier for patients to stick with. St. Jude is at the forefront of clinical research to bring these treatments to children and young adults. St. Jude has a long history of working with the National Institutes of Health (NIH)-funded International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network. Aditya Gaur, MD, St. Jude Division of HIV Medicine director co-led the IMPAACT 2017 study, whose primary goal was to determine the safety of these medicines and drug exposure in adolescents aged 12 to 18. Results from the Phase 1/2 clinical trial show that a long-acting, injectable treatment regimen is safe for use in this age group. “A few decades from now, we will reflect and say this was another milestone in how we addressed the management of HIV,” said Aditya Gaur, MD, St. Jude Division of HIV Medicine director. “Long-acting HIV treatment adds yet another treatment option for people living with HIV.” Findings from the first study cohort, published in The Lancet HIV, showed no serious adverse effects in these patients. These interim findings informed the approval of this combination of long-acting medications for adolescents by the U.S. Food and Drug Administration (FDA) and Canada Health. “At an individual level,” Gaur concluded. “It’s most rewarding to hear the testimonies of the adolescents who shared what it meant for them not to have to take daily oral medications and to experience some relief from the feeling of stigma.” Learn more about the study on Progress: https://ow.ly/E20x50StLI7
St. Jude Children's Research Hospital’s Post
More Relevant Posts
-
📃Scientific paper: Linkage to HIV Care and Early Retention in Care Rates in the Universal Test-and-Treat Era: A Population-based Prospective Study in KwaZulu-Natal, South Africa Abstract: HIV linkage, and retention are key weaknesses in South Africa’s national antiretroviral therapy (ART) program, with the greatest loss of patients in the HIV treatment pathway occurring before ART initiation. This study investigated linkage-to and early-retention-in-care (LTRIC) rates among adults newly diagnosed with HIV in a high-HIV prevalent rural district. We conducted an observational prospective cohort study to investigate LTRIC rates for adults with a new HIV diagnosis in South Africa. Patient-level survey and clinical data were collected using a one-stage-cluster design from 18 healthcare facilities and triangulated between HIV and laboratory databases and registered deaths from Department of Home Affairs. We used Chi-square tests to assess associations between categorical variables, and results were stratified by HIV status, sex, and age. Of the 5,637 participants recruited, 21.2% had confirmed HIV, of which 70.9% were women, and 46.5% were aged 25–34 years. Although 82.7% of participants were linked-to-care within 3 months, only 46.1% remained-in-care 12 months after initiating ART and 5.2% were deceased. While a significantly higher proportion of men were linked-to-care at 3 months compared to women, a significant proportion of women (49.5%) remained-in-care at 12 months than men (38.0%). Post-secondary education and child support grants were significantly associated with retention. We found high linkage-to-care rates, but less than 50% of participants r... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/0owAq
To view or add a comment, sign in
-
📃Scientific paper: Factors associated to neurocognitive impairment in older adults living with HIV Abstract: Objective The HIV infection is a chronic disease that causes neurocognitive impairment (NI) and has been related with early development of frailty. We aimed to study the main risk factors for neurocognitive disorders and frailty in HIV older adults. Materials and methods Cross-sectional study with 40 HIV individuals older than 65 years under antiretroviral therapy in Hospital del Mar (Barcelona) recruited between November 2019 and October 2020. Data has been obtained through clinical scores and a blood sample to evaluate NI and frailty and has been analyzed with non-parametric tests and a multivariate logistic regression model. Results Among the 40 patients admitted for the study, 14 (35%) had positive screening for NI. We found that HIV individuals with nadir CD4+ T-cell count lower than 350 cells/mm^3 had 39.7 more risk for NI (95% CI 2.49–632.10; p = 0.009). Those with a lower education level had 22.78 more risk for neurocognitive disorders (95% CI 2.13–242.71; p = 0.01) and suffering any comorbidity with a punctuation ≥ 1 in the Charlson Comorbidity index had an increased risk of 18.26 of developing NI and frailty (95% CI 1.30–256.33; p = 0.031), among them diabetes was significantly more frequent in NI. Conclusion We observed that the main risk factors for a positive NI screening in HIV older adults were low education level, a nadir CD4+ T-cell count < 350 cells/mm^3 and the presence of any comorbidity, highlighting diabetes among them. Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/rHmOn
Factors associated to neurocognitive impairment in older adults living with HIV
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Utilization of provider-initiated HIV testing and counselling in Ethiopia: a systematic review and meta-analysis Abstract: Background Provider-initiated HIV testing, and counseling (PITC) is a service in which health professionals provide HIV testing to all patients in health facilities. Provider-initiated HIV testing, and counseling is an important opportunity for early screening of individuals, and it is fundamental for both HIV treatment and prevention. Although there are studies conducted in different parts of Ethiopia, their findings are variable. Therefore, this systematic review and meta-analysis aimed to summarize the pooled utilization of PITC in Ethiopia. Method All studies conducted on utilization of provider-initiated HIV testing and counseling at outpatient departments (OPD), inpatient departments (IPD), antenatal clinic care (ANC), and tuberculosis (TB) clinics in Ethiopia are eligible for these meta-analyses. A systematic search of the literature was conducted by the authors to identify all relevant primary studies. The databases used to search for studies were PubMed, Science Direct, POPLINE, HENARI, Google Scholar, and Scopus. The extracted data were imported into STATA version 14 software for statistical analysis. The risk of bias was assessed using the Joana Briggs Institute (JBI) criteria for prevalence studies. The heterogeneity among all included studies was assessed by I ^2 statistics and the Cochran’s Q test. Pooled utilization along with its corresponding 95% CI was presented using a forest plot. Result About 1738 studies were retrieved from initial electroni... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/c7p
Utilization of provider-initiated HIV testing and counselling in Ethiopia: a systematic review and meta-analysis
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Improving retention and HIV viral load suppression among adolescents living with HIV in TASO Soroti and TASO Mbale centers of excellence using Operation Triple Zero model: a before and after study protocol Abstract: Background Retention in care and HIV viral load suppression remains sub-optimal among HIV positive adolescents in many settings including TASO Uganda, despite the implementation of interventions such as regimen optimization and community-based approaches like multi-month drug dispensing. To this end, the implementation of additional intervention is urgently required to address gaps in current programming which include inadequate centralization of the HIV positive adolescents and their caregivers in the designs. This study, thus, proposes to adapt and implement the Operation Triple Zero (OTZ) model in TASO Soroti and Mbale centers to improve both retention and viral load suppression among the adolescents living with HIV. Methodology A before and after study design is preferred, employing both qualitative and quantitative approaches. To identify barriers and facilitators to retention and HIV viral load suppression among the HIV positive adolescents, secondary data, focused group discussions, and key informant interviews will be used to understand perspectives of the adolescents, their caregivers, and the health-workers. The Consolidated Framework for Implementation Research (CFIR) will help in designing the intervention, while Knowledge to Action (K2A) will support the adaptation process. To test the intervention, Reach, Effectiveness, Adaption, Implementation and Maintenance (RE-AIM) framework will be used. A paired t -test will be used to compare means of retention a... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/Hb8ml
Improving retention and HIV viral load suppression among adolescents living with HIV in TASO Soroti and TASO Mbale centers of excellence using Operation Triple Zero model: a before and after study protocol
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Factors associated to neurocognitive impairment in older adults living with HIV Abstract: Objective The HIV infection is a chronic disease that causes neurocognitive impairment (NI) and has been related with early development of frailty. We aimed to study the main risk factors for neurocognitive disorders and frailty in HIV older adults. Materials and methods Cross-sectional study with 40 HIV individuals older than 65 years under antiretroviral therapy in Hospital del Mar (Barcelona) recruited between November 2019 and October 2020. Data has been obtained through clinical scores and a blood sample to evaluate NI and frailty and has been analyzed with non-parametric tests and a multivariate logistic regression model. Results Among the 40 patients admitted for the study, 14 (35%) had positive screening for NI. We found that HIV individuals with nadir CD4+ T-cell count lower than 350 cells/mm^3 had 39.7 more risk for NI (95% CI 2.49–632.10; p = 0.009). Those with a lower education level had 22.78 more risk for neurocognitive disorders (95% CI 2.13–242.71; p = 0.01) and suffering any comorbidity with a punctuation ≥ 1 in the Charlson Comorbidity index had an increased risk of 18.26 of developing NI and frailty (95% CI 1.30–256.33; p = 0.031), among them diabetes was significantly more frequent in NI. Conclusion We observed that the main risk factors for a positive NI screening in HIV older adults were low education level, a nadir CD4+ T-cell count < 350 cells/mm^3 and the presence of any comorbidity, highlighting diabetes among them. Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/I1L
Factors associated to neurocognitive impairment in older adults living with HIV
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder Abstract: HIV and major depressive disorder (MDD) commonly co-occur and are both linked to greater risk-taking behavior, possibly due to neurocognitive impairment (NCI). The present study examined the concordance of the Balloon Analog Risk Task (BART), a gold standard measure of risk-taking propensity, with NCI and real-world sexual risk behaviors in PWH with comorbid MDD. Participants included 259 adults, stratified by HIV serostatus (HIV + /HIV −) and lifetime MDD (MDD + /MDD −), who completed neuropsychological testing, the BART, and sexual risk behavior questionnaires. Logistic regression, stratified by HIV serostatus, examined joint effects of MDD and BART (linear and quadratic) on NCI. Follow-up linear regressions examined sexual risk behavior and neurocognitive domain T-scores as correlates of the BART. NCI prevalence was lowest in HIV − /MDD − , but BART scores did not differ by HIV/MDD status. In the HIV + group, BART performance predicted NCI such that high and low BART scores related to greater odds of NCI, but only in dual-risk HIV + /MDD + individuals. HIV + /MDD + individuals with both low and high BART scores exhibited poorer learning and recall, whereas processing speed and executive function were only poor in low BART risk-taking HIV + /MDD + . Higher BART scores linearly related to higher sexual risk behaviors only in MDD + individuals, independent of HIV serostatus. Low and high risk-taking on the BART may reflect discrete neurocognitive profiles in HIV + ... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/Ulh3
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial Abstract: HIV incidence among women in Eastern and Southern Africa remains unacceptably high, highlighting the need for effective HIV prevention options, including pre-exposure prophylaxis (PrEP). The Evidence for Contraceptive Options and HIV Outcomes trial offered daily oral PrEP to participants during the latter part of the clinical trial as an additional HIV prevention choice. We explored daily oral PrEP continuation at trial exit among women enrolled from Durban, South Africa who initiated oral PrEP at the trial site. Of the 132 women initiating oral PrEP, 87% reported continuation of oral PrEP at month 1, 80% at month 3, and 75% continued using oral PrEP at their final trial visit and were referred to off-site facilities for ongoing oral PrEP access. The median duration of oral PrEP use in trial participants who used oral PrEP was 91 days (IQR 87 to 142 days). Women who disclosed their oral PrEP use to someone had increased odds of continuing oral PrEP at trial exit. Women who reported > 1 sex partner and those who felt they would probably or definitely get infected with HIV had reduced odds of continuing oral PrEP at trial exit. Of those discontinuing oral PrEP (n = 32), > 50% discontinued within the first month, and the most common reason for discontinuation was reporting side effects. The high rates of oral PrEP continuation in our study are encouraging and our findings can be utilized by other clinical trials providing oral PrEP as standard of care for HIV preventio... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/LS
Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial
ethicseido.com
To view or add a comment, sign in
-
📃Scientific paper: Enhancing linkage to HIV care in the “Universal Test and Treat” era: Barriers and enablers to HIV care among adults in a high HIV burdened district in KwaZulu-Natal, South Africa Abstract: Ending AIDS by 2030 would depend on how successful health systems are in linking people living with HIV (PLHIV) into care. The World Health Organization recommended the ‘Universal Test and Treat’ (UTT) strategy – initiating all individuals testing positive on antiretroviral therapy (ART) irrespective of their CD4 count and clinical staging. This study aimed to explore the enablers and barriers to linkage to HIV care among adults with a new HIV diagnosis in a high-HIV prevalent rural district in South Africa. A qualitative study was undertaken to explore patients’ perceptions of enablers and barriers of linkage-to-care, using a life-story narration and dialogue approach. In-depth interviews were conducted with 38 HIV-positive participants sampled from a cohort of 1194 HIV-positive patients recruited from December 2017 to June 2018. Participants were selected based on whether they had been linked to care or not within 3 months of positive HIV diagnosis. Interviews were thematically analysed using a general inductive approach. Of the 38 participants, 22 (58%) linked to care within three months of HIV-positive diagnosis. Factors that facilitated or inhibited linkage-to-care were found at individual, family, community, as well as health systems levels. Enablers included a positive HIV testing experience, and assistance from the fieldwork team. Support from family, and friends, as well as prior community-based education about HIV and ART were also noted. Individual fac... Discover the rest of the scientific article on es/iode ➡️https://etcse.fr/ASm9j
Enhancing linkage to HIV care in the “Universal Test and Treat” era: Barriers and enablers to HIV care among adults in a high HIV burdened district in KwaZulu-Natal, South Africa
ethicseido.com
To view or add a comment, sign in
-
In the last four decades,amazing progress has been made in the management of HIV. Miraculously, AIDS, the advanced stage of HIV disease, has transformed from disease characterised by certain deaths within 2 years, to a manageable chronic disease with an almost normal life expectancy. Managing millions of patients in the public health care system remains a huge challenge. Recent data suggests that at least one in five patients are still presenting late with life threatening conditions associated with low CD4 T-cell counts, one in four disengage from care within the first year of linkage, and up to one in three fail to maintain fully suppressed viral loads despite firm linkage to care. The value of treatment in reducing transmission, improving quality of life and overall life expectancy cannot be over-emphasised. Considering this landscape, it is imperative that all clinicians continue sharpening and maintaining their many clinical skills, from understanding current treatment regimens, toxicities and drug interactions, to detecting and managing associated diseases of aging while being able to recognise advanced HIV disease, including diagnosing and managing the many life-threatening opportunistic infections. We gather at the backdrop of the UNAIDS report (2023) that affirmed the possibility of eliminating AIDS as a public health concern by 2030. As researchers, scientists, policy makers, leaders and clinicians we heed to the call to endevour towards the 95-95-95 targets by 2030. I am grateful to the employer of choice, Ubombo Sugar Limited for affording me this eye opening experience.
To view or add a comment, sign in
-
📃Scientific paper: The biobehavioral Women’s Health CoOp in Pretoria, South Africa: study protocol for a cluster-randomized design Abstract: BACKGROUND: South Africa has 6.4 million adults over the age of 15 living with HIV. Gender inequality issues continue to drive the HIV epidemic in South Africa, where Black African women bear the greatest HIV burden. Limited access to services; little capacity to negotiate sex and condom use; and other legal, social, and economic inequities make women highly vulnerable to HIV infection. Behavioral interventions have been shown to decrease risk behaviors, but they have been less successful in reducing HIV incidence. Conversely, biomedical prevention strategies have proven to be successful in reducing HIV incidence, but require behavioral interventions to increase uptake and adherence. Consequently, there is a need for integrated approaches that combine biomedical and behavioral interventions. Effective combination prevention efforts should comprise biomedical, behavioral, and structural programming proven in randomized trials that focuses on the driving forces and key populations at higher risk of HIV infection and transmission. METHODS/DESIGN: This prospective, geographically clustered randomized field experiment is enrolling participants into two arms: a control arm that receives standard HIV testing and referral for treatment; and an intervention arm that receives an evidence-based, woman-focused behavioral intervention that emphasizes risk reduction and retention, the Women’s Health CoOp. We divided the city of Pretoria into 14 mutually exclusive geographic zones... Continued on ES/IODE ➡️ https://etcse.fr/jCdH ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.
The biobehavioral Women’s Health CoOp in Pretoria, South Africa: study protocol for a cluster-randomized design
ethicseido.com
To view or add a comment, sign in
77,666 followers
More from this author
-
Progress in HIV/AIDS Research and Treatment
St. Jude Children's Research Hospital 1y -
St. Jude is changing the way patients education resources are delivered
St. Jude Children's Research Hospital 1y -
Encouraging HPV Vaccination as Cancer Prevention in Rural Communities
St. Jude Children's Research Hospital 1y